Genomtec develops rapid, portable genetic diagnostics, with a strong patent portfolio and significant funding for its OncoSNAAT oncology project. The company is advancing M&A discussions, has restructured for transaction efficiency, and maintains a secure financial position through grants and a recent share issue.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.